$PRE

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.9%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, the US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported. Claritev shares fell 5.1%.HCA Healthcare (HCA) shares dropped 7.2% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut its price target on the stock to $480 from $500, while keeping its overweight rating.IM8, a nutritional supplements company co-founded by Prenetics Global (PRE) and David Beckham, has lined up about $1 billion in growth financing from General Catalyst, Bloomberg reported. Prenetics shares jumped 17%.NextCure (NXTC) shares almost tripled after the company agreed to merge with privately held Avere Therapeutics in an all-stock deal.

Sector Update: Healthcare

Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index down 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1.9%.The iShares Biotechnology ETF (IBB) was down 0.4%.In corporate news, IM8, a nutritional supplements company co-founded by Prenetics Global (PRE) and David Beckham, has lined up about $1 billion in growth financing from General Catalyst, Bloomberg reported. Prenetics shares rose 15%.

Market Chatter: IM8, Co-Founded by Prenetics and David Beckham, Gets General Catalyst Financing

IM8, a nutritional supplements company co-founded by Prenetics Global (PRE) and David Beckham, has lined up about $1 billion in growth financing from General Catalyst, Bloomberg reported, citing a statement.General Catalyst's Customer Value Fund will finance up to 70% of IM8's marketing costs, and the venture capital firm will receive a share of the income, capped at a certain threshold, the report said.Prenetics and General Catalyst didn't immediately reply to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $18.56, Change: $-0.12, Percent Change: -0.64%

Prenetics and Beckham's IM8 Secures $1 Billion in Financing From General Catalyst, Bloomberg Reports

Prenetics and Beckham's IM8 Secures $1 Billion in Financing From General Catalyst, Bloomberg Reports

Benchmark Initiates Prenetics Global at Buy With $30 Price Target

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks fell late Wednesday afternoon with the NYSE Healthcare Index declining 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1%.The iShares Biotechnology ETF (IBB) fell 1.8%.In corporate news, Prenetics Global (PRE) shares dropped 8.7% after the company reported a Q1 loss of $1.36 per diluted share, widening from the loss of $0.80 a year earlier.Sanofi (SNY) shares fell 2.3%. The company said it will discontinue a phase 3 trial of riliprubart in patients with a type of chronic inflammatory demyelinating polyneuropathy after an interim review found the study was unlikely to provide sufficient efficacy.Johnson & Johnson (JNJ) was ordered by a Los Angeles jury to pay $32 million to the family of a California woman who died from pleural mesothelioma after alleged exposure to asbestos-contaminated talc, according to the law firm representing the family. Johnson & Johnson shares rose 0.7%.Pfizer's (PFE) recent share decline has pulled its valuation back toward historical levels, easing some of the concerns raised in its earlier outlook, RBC Capital Markets said. Pfizer's stock fell 0.2%.

Sector Update: Healthcare Stocks Decline in Afternoon Trading

Healthcare stocks were lower Wednesday afternoon, with the NYSE Healthcare Index down 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.9%.The iShares Biotechnology ETF (IBB) fell 1.2%.In corporate news, Prenetics Global (PRE) shares dropped 7% after the company reported a Q1 loss of $1.36 per diluted share, wider than a loss of $0.80 a year earlier.Sanofi (SNY) shares fell 2.3%. The firm said it will discontinue a phase 3 trial of riliprubart in patients with a type of chronic inflammatory demyelinating polyneuropathy after an interim review found the study was unlikely to provide sufficient efficacy.Johnson & Johnson (JNJ) was ordered by a Los Angeles jury to pay $32 million to the family of a California woman who died from pleural mesothelioma after alleged exposure to asbestos-contaminated talc, according to the law firm representing the family. Johnson & Johnson shares were up 0.8%.

Sector Update: Healthcare

Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index down 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.6%.The iShares Biotechnology ETF (IBB) fell 0.8%.In corporate news, Prenetics Global (PRE) shares shed more than 7% after the company reported a Q1 loss Wednesday of $1.36 per diluted share, wider than a loss of $0.80 a year earlier. Four analysts surveyed by FactSet expected a loss of $0.84.